Cambridge Antibody Technology
British company
Quick Summary
Cambridge Antibody Technology was a British company founded in 1989 by Nobel laureate Gregory P. Winter. The company was instrumental in the development of therapeutic antibodies, particularly through Winter's pioneering work in phage display technology. This technology allows for the creation of fully human antibodies, overcoming the immune reactions that can occur with mouse-derived antibodies. Cambridge Antibody Technology was later acquired by AstraZeneca.12
Summary created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
2 Britannica Sources
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.